⌘K

Login Start Free

Home/Filings/4/0001209191-20-054250

4//SEC Filing

Thomas Dolca 4

Accession 0001209191-20-054250

CIK 0001435049other

View on SEC.gov Company Profile

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 9:06 PM ET

Size

5.4 KB

Accession

0001209191-20-054250

Insider Transaction Report

Form 4

Period: 2020-10-06

ADURO BIOTECH, INC.KDNY

Director

Transactions

Award
Stock Option (right to buy)
2020-10-06+23,522→ 23,522 total
Exercise: $14.77Exp: 2030-10-05→ Common Stock (23,522 underlying)

Footnotes (1)

[F1]The stock option vests as of 1/36 of the total shares monthly beginning on November 6, 2020 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1

filerCIK 0001768239

Filing Metadata

Form type: 4
Filed: Oct 6, 8:00 PM ET
Accepted: Oct 7, 9:06 PM ET
Size: 5.4 KB

View on SEC.gov